Individualized immunoglobulin therapy in chronic immune‐mediated peripheral neuropathies.
Abstract: Despite the well‐recognized importance of immunoglobulin therapy individualization during the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), the pathway to best achieve optimization is unknown. There are many pharmacokinetic and immunobiologic variables that can pot...
| Publicado en: | Journal of the Peripheral Nervous System Vol. 23; no. 2; pp. 78 - 88 |
|---|---|
| Autores principales: | , , , , |
| Formato: | algorithm pictorial review tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Jun2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |